These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 18274746)

  • 41. Clonal Immunoglobulin against Lysolipids in the Origin of Myeloma.
    Nair S; Branagan AR; Liu J; Boddupalli CS; Mistry PK; Dhodapkar MV
    N Engl J Med; 2016 Feb; 374(6):555-61. PubMed ID: 26863356
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Benefits of new immunoglobulin-derived biomarkers for the diagnosis and follow-up of patients with dysglobulinemia.
    Ermak N; Nguyen-Khoa T; Alyanakian MA
    Ann Biol Clin (Paris); 2016 Oct; 74(5):597-605. PubMed ID: 27707674
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Saposin C is a frequent target of paraproteins in Gaucher disease-associated MGUS/multiple myeloma.
    Preuss KD; Hollak CEM; Fadle N; van Oers M; Regitz E; Pfreundschuh M
    Br J Haematol; 2019 Feb; 184(3):384-391. PubMed ID: 30450574
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Monoclonal gammopathy of undetermined significance and smoldering multiple myeloma.
    Kyle RA; San-Miguel JF; Mateos MV; Rajkumar SV
    Hematol Oncol Clin North Am; 2014 Oct; 28(5):775-90. PubMed ID: 25212882
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Double gammopathies: incidence and clinical course of 20 patients.
    Nilsson T; Norberg B; Rudolphi O; Jacobsson L
    Scand J Haematol; 1986 Jan; 36(1):103-6. PubMed ID: 3081993
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Increased risk of monoclonal gammopathy in first-degree relatives of patients with multiple myeloma or monoclonal gammopathy of undetermined significance.
    Vachon CM; Kyle RA; Therneau TM; Foreman BJ; Larson DR; Colby CL; Phelps TK; Dispenzieri A; Kumar SK; Katzmann JA; Rajkumar SV
    Blood; 2009 Jul; 114(4):785-90. PubMed ID: 19179466
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Serum free light chain ratio is an independent risk factor for progression in monoclonal gammopathy of undetermined significance.
    Rajkumar SV; Kyle RA; Therneau TM; Melton LJ; Bradwell AR; Clark RJ; Larson DR; Plevak MF; Dispenzieri A; Katzmann JA
    Blood; 2005 Aug; 106(3):812-7. PubMed ID: 15855274
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Lymphoplasmacytic lymphoma with monoclonal gammopathy-related pseudo-Gaucher cell infiltration in bone marrow and spleen--diagnostic and therapeutic dilemmas.
    Robak T; Urbańska-Ryś H; Jerzmanowski P; Bartkowiak J; Liberski P; Kordek R
    Leuk Lymphoma; 2002 Dec; 43(12):2343-50. PubMed ID: 12613522
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Prevalence and predictors of liver fibrosis evaluated by vibration controlled transient elastography in type 1 Gaucher disease.
    Nascimbeni F; Cassinerio E; Dalla Salda A; Motta I; Bursi S; Donatiello S; Spina V; Cappellini MD; Carubbi F
    Mol Genet Metab; 2018 Sep; 125(1-2):64-72. PubMed ID: 30115580
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Gaucher's disease associated with monoclonal gammapathy of undetermined significance: a case report.
    Airò R; Gabusi G; Guindani M
    Haematologica; 1993; 78(2):129-31. PubMed ID: 8349190
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [A series of 618 cases of monoclonal gammopathies of undetermined significance: predictive factors of disappearance of monoclonal component or evolution to malignant gammopathies].
    González García ME; Fernández Alvarez C; Robles Marinas V; González Huerta AJ; Arias Miranda MI; González Rodríguez AP; García Casas J; de La Tassa JM; Fernández García J
    Rev Clin Esp; 2008 Jun; 208(6):288-94. PubMed ID: 18620653
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Laboratory and clinical characterization of monoclonal gammopathy in Taiwanese.
    Lee LN; Jan IS; Tien HF; Lin JS; Lo SC; Cheng WC
    J Formos Med Assoc; 2002 Feb; 101(2):91-7. PubMed ID: 12099210
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Diagnostic value of serum IL-6 level in monoclonal gammopathies.
    DuVillard L; Guiguet M; Casasnovas RO; Caillot D; Monnier-Zeller V; Bernard A; Guy H; Solary E
    Br J Haematol; 1995 Feb; 89(2):243-9. PubMed ID: 7873373
    [TBL] [Abstract][Full Text] [Related]  

  • 54. MGUS and smoldering multiple myeloma: update on pathogenesis, natural history, and management.
    Rajkumar SV
    Hematology Am Soc Hematol Educ Program; 2005; ():340-5. PubMed ID: 16304401
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Adult Fanconi syndrome secondary to light chain gammopathy. Clinicopathologic heterogeneity and unusual features in 11 patients.
    Messiaen T; Deret S; Mougenot B; Bridoux F; Dequiedt P; Dion JJ; Makdassi R; Meeus F; Pourrat J; Touchard G; Vanhille P; Zaoui P; Aucouturier P; Ronco PM
    Medicine (Baltimore); 2000 May; 79(3):135-54. PubMed ID: 10844934
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Magnetic resonance imaging of bone marrow changes in Gaucher disease during enzyme replacement therapy: first German long-term results.
    Poll LW; Koch JA; vom Dahl S; Willers R; Scherer A; Boerner D; Niederau C; Häussinger D; Mödder U
    Skeletal Radiol; 2001 Sep; 30(9):496-503. PubMed ID: 11587517
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Kynurenic acid in blood and bone marrow plasma of monoclonal gammopathy of undetermined significance (MGUS) and multiple myeloma (MM) patients.
    Zdzisińska B; Wejksza K; Walter-Croneck A; Turski WA; Kandefer-Szerszeń M
    Leuk Res; 2010 Jan; 34(1):38-45. PubMed ID: 19596432
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Serum free light chains in clinical laboratory diagnostics.
    Jenner E
    Clin Chim Acta; 2014 Jan; 427():15-20. PubMed ID: 23999048
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Association of plasma cell subsets in the bone marrow and free light chain concentrations in the serum of monoclonal gammopathy patients.
    Ayliffe MJ; Behrens J; Stern S; Sumar N
    J Clin Pathol; 2012 Aug; 65(8):758-61. PubMed ID: 22659334
    [TBL] [Abstract][Full Text] [Related]  

  • 60. PD-L1/PD-1 Pattern of Expression Within the Bone Marrow Immune Microenvironment in Smoldering Myeloma and Active Multiple Myeloma Patients.
    Costa F; Vescovini R; Marchica V; Storti P; Notarfranchi L; Dalla Palma B; Toscani D; Burroughs-Garcia J; Catarozzo MT; Sammarelli G; Giuliani N
    Front Immunol; 2020; 11():613007. PubMed ID: 33488620
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.